Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate for post-tonsillectomy pain and agitation in children
IRCT20211121053130N1Phase 3Completed
- Sponsor
- Fasa University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of magnesium sulfate in postoperative pain and postoperative delirium (POD) (3 arms), sponsored by Fasa University of Medical Sciences. Primary endpoint: Decrease in pain post-tonsillectomy. Started Dec 2021; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
postoperative painpostoperative delirium (POD)
Beyond the preview
Go deeper on IRCT20211121053130N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211121053130N1.